A detailed history of United Capital Financial Advisers, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 15,080 shares of EW stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,080
Previous 17,502 13.84%
Holding current value
$1.12 Million
Previous $1.62 Million 38.43%
% of portfolio
0.01%
Previous 0.01%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$59.7 - $93.78 $144,593 - $227,135
-2,422 Reduced 13.84%
15,080 $995,000
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $1 Million - $1.12 Million
-11,880 Reduced 40.43%
17,502 $1.62 Million
Q1 2024

May 15, 2024

SELL
$72.54 - $95.56 $96,042 - $126,521
-1,324 Reduced 4.31%
29,382 $2.81 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $303,181 - $382,034
-4,913 Reduced 13.79%
30,706 $2.34 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $243,172 - $327,763
-3,510 Reduced 8.97%
35,619 $2.47 Million
Q2 2023

Aug 14, 2023

SELL
$81.41 - $94.33 $163,227 - $189,131
-2,005 Reduced 4.87%
39,129 $3.69 Million
Q1 2023

Aug 14, 2023

BUY
$74.26 - $84.51 $104,335 - $118,736
1,405 Added 3.59%
40,534 $3.35 Million
Q1 2023

May 15, 2023

BUY
$74.26 - $84.51 $287,460 - $327,138
3,871 Added 10.39%
41,134 $3.4 Million
Q4 2022

Feb 14, 2023

BUY
$68.3 - $87.44 $1.52 Million - $1.95 Million
22,295 Added 148.95%
37,263 $2.78 Million
Q3 2022

Nov 14, 2022

SELL
$82.37 - $107.29 $287,471 - $374,442
-3,490 Reduced 18.91%
14,968 $1.24 Million
Q2 2022

Aug 11, 2022

BUY
$86.5 - $128.27 $209,330 - $310,413
2,420 Added 15.09%
18,458 $1.76 Million
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $152,940 - $192,510
-1,500 Reduced 8.55%
16,038 $1.89 Million
Q4 2021

Feb 14, 2022

BUY
$106.37 - $130.68 $5,850 - $7,187
55 Added 0.31%
17,538 $2.27 Million
Q3 2021

Nov 15, 2021

SELL
$102.91 - $122.75 $1.35 Million - $1.61 Million
-13,094 Reduced 42.82%
17,483 $1.98 Million
Q2 2021

Aug 13, 2021

BUY
$83.84 - $104.76 $79,564 - $99,417
949 Added 3.2%
30,577 $3.17 Million
Q1 2021

May 14, 2021

SELL
$78.68 - $90.67 $242,727 - $279,716
-3,085 Reduced 9.43%
29,628 $2.48 Million
Q4 2020

Feb 17, 2021

SELL
$71.69 - $91.23 $182,451 - $232,180
-2,545 Reduced 7.22%
32,713 $2.98 Million
Q3 2020

Nov 13, 2020

SELL
$67.19 - $87.44 $743,121 - $967,086
-11,060 Reduced 23.88%
35,258 $2.81 Million
Q2 2020

Aug 13, 2020

BUY
$57.54 - $76.95 $641,110 - $857,376
11,142 Added 31.68%
46,318 $3.2 Million
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $436,103 - $674,001
8,321 Added 30.98%
35,176 $6.64 Million
Q4 2019

Feb 14, 2020

BUY
$71.7 - $82.09 $1,864 - $2,134
26 Added 0.1%
26,855 $6.27 Million
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $210,254 - $257,668
-3,416 Reduced 11.29%
26,829 $5.9 Million
Q2 2019

Aug 13, 2019

SELL
$55.74 - $64.41 $7,301 - $8,437
-131 Reduced 0.43%
30,245 $5.59 Million
Q1 2019

May 14, 2019

BUY
$47.89 - $64.05 $29,691 - $39,711
620 Added 2.08%
30,376 $5.81 Million
Q4 2018

Feb 14, 2019

BUY
$46.41 - $56.94 $31,465 - $38,605
678 Added 2.33%
29,756 $4.56 Million
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $136,780 - $173,683
2,993 Added 11.47%
29,078 $5.06 Million
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $88,465 - $106,909
2,084 Added 8.68%
26,085 $3.8 Million
Q1 2018

May 15, 2018

BUY
$37.19 - $47.45 $580,424 - $740,552
15,607 Added 185.93%
24,001 $3.35 Million
Q4 2017

Feb 13, 2018

SELL
$33.79 - $39.39 $181,925 - $212,075
-5,384 Reduced 39.08%
8,394 $946,000
Q3 2017

Nov 14, 2017

BUY
$36.29 - $38.83 $94,716 - $101,346
2,610 Added 23.37%
13,778 $1.51 Million
Q2 2017

Aug 14, 2017

BUY
N/A
11,168
11,168 $1.32 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track United Capital Financial Advisers, LLC Portfolio

Follow United Capital Financial Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.